01/08/2010 - Reviews

ABCC2/Abcc2: a multispecific transporter with dominant excretory functions

K. Jemnitz, K. Heredi-Szabo, L Vereczkey and P. Krajcsi

Drug Metab Rev. 2010 Aug;42(3):402-36.


ABCC2/Abcc2 (MRP2/Mrp2) is expressed at major physiological barriers, such as the canalicular membrane of liver cells, kidney proximal tubule epithelial cells, enterocytes of the small and large intestine, and syncytiotrophoblast of the placenta. ABCC2/Abcc2 always localizes in the apical membranes. Although ABCC2/Abcc2 transports a variety of amphiphilic anions that belong to different classes of molecules, such as endogenous compounds (e.g., bilirubin-glucuronides), drugs, toxic chemicals, nutraceuticals, and their conjugates, it displays a preference for phase II conjugates. Phenotypically, the most obvious consequence of mutations in ABCC2 that lead to Dubin-Johnson syndrome is conjugate hyperbilirubinemia. ABCC2/Abcc2 harbors multiple binding sites and displays complex transport kinetics.

open_in_new Read the Source

Next: A novel screening strategy to identify ABCB1 substrates and inhibitors

Previous: Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays